{"schema_version":"secwatch.filing_event.v1","accession":"0001564590-22-017846","form_type":"8-K","ticker":"SDGR","cik":"0001490978","company_name":"Schrodinger, Inc.","filed_at":"2022-05-04T23:59:59+00:00","discovered_at":"2026-05-14T18:04:00.893375+00:00","generated_at":"2026-06-26T00:36:54.464850+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"Schrödinger Q1 total revenue up 51% to $48.7M; net loss widens to $34.5M","bullets":["Software revenue $33.1M (+26% YoY); drug discovery revenue $15.6M (+169% YoY).","Net loss of $34.5M compared to $0.5M loss in Q1 2021.","Maintains full-year 2022 total revenue guidance of $161M-$181M.","Cash, equivalents, and marketable securities of ~$529M; MALT1 IND on track for H1 2022.","Software gross margin 77%; operating expenses $56.6M, up 41% YoY."],"urls":{"canonical":"https://secwatch.observer/filing/0001564590-22-017846","json":"https://secwatch.observer/filing/0001564590-22-017846.json","markdown":"https://secwatch.observer/filing/0001564590-22-017846.md","text":"https://secwatch.observer/filing/0001564590-22-017846.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1490978/000156459022017846/0001564590-22-017846-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1490978/000156459022017846/sdgr-8k_20220504.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-26T00:36:54.464850+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}